AVANT DIAGNOSTICS INC Inactive Instrument
Company Avant Diagnostics Inc
Equities
US05350M1062
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 2021 | Avant Diagnostics : AvidXchange Shares Fall in Trading Debut | MT |
| 2021 | Avant Diagnostics : AvidXchange Prices IPO at $25 Per Share | MT |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Michael Ruxin
CEO | Chief Executive Officer | 78 | 17-11-30 |
Thomas Chilcott
DFI | Director of Finance/CFO | 56 | 20-09-23 |
Glenn D. Hoke
CTO | Chief Tech/Sci/R&D Officer | - | 16-05-11 |
Trevor McCartney
PRN | Corporate Officer/Principal | - | 19-02-28 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jeffrey Busch
CHM | Chairman | 66 | 18-05-24 |
Michael Ruxin
CEO | Chief Executive Officer | 78 | 17-11-30 |
| Director/Board Member | 43 | - | |
| 51 | - | ||
Yvonne Fors
BRD | Director/Board Member | 52 | 99-12-31 |
Matthew Schwartz
BRD | Director/Board Member | 50 | - |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 336,957,722 | 9,119,130 ( 2.706 %) | 0 | 2.706 % |
Holdings
| Name | Equities | % | Valuation |
|---|---|---|---|
THERALINK TECHNOLOGIES, INC. 100.00% | 1,000 | 100.00% | 10 $ |
Company contact information
Theralink Technologies, Inc. (Colorado)
15000 West 6th Avenue Suite 400
80401, Golden
+
https://theralink.com
Sector
| 1st Jan change | Capi. | |
|---|---|---|
| -40.31% | 8.15B | |
| +8.65% | 3.6B | |
| -0.25% | 2.27B | |
| -24.56% | 1.9B | |
| -18.21% | 1.72B | |
| +5.95% | 922M | |
| +16.75% | 731M | |
| -10.48% | 679M | |
| -0.60% | 288M |
- Stock Market
- Equities
- Stock
- Company Avant Diagnostics Inc
